Literature DB >> 7547102

HLA-B27 and its subtypes in world populations.

M A Khan.   

Abstract

Twenty-five years ago, HLA-B27 was recognized as a new HLA specificity. It is present throughout Eurasia but is virtually absent among the genetically unmixed native populations of South America, the Bantus and Sans (Bushmen) of equatorial and southern Africa, and the aborigines of Australia. B27 is a serologically determined specificity that encompasses nine different allotypes (subtypes), B*2701 to B*2709. Ankylosing spondylitis or related spondyloarthropathies thus far have been documented in individuals with any of the following five subtypes: B*2701, B*2702, B*2704, B*2705, or B*2707.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7547102     DOI: 10.1097/00002281-199507000-00001

Source DB:  PubMed          Journal:  Curr Opin Rheumatol        ISSN: 1040-8711            Impact factor:   5.006


  58 in total

Review 1.  Rheumatic disease and the Australian aborigine.

Authors:  R A Roberts-Thomson; P J Roberts-Thomson
Journal:  Ann Rheum Dis       Date:  1999-05       Impact factor: 19.103

2.  Population dynamics of rapid fixation in cytotoxic T lymphocyte escape mutants of influenza A.

Authors:  Julia R Gog; Guus F Rimmelzwaan; Albert D M E Osterhaus; Bryan T Grenfell
Journal:  Proc Natl Acad Sci U S A       Date:  2003-09-03       Impact factor: 11.205

3.  Four cases of ankylosing spondylitis in medieval skeletal series from Croatia.

Authors:  Mario Slaus; Mario Novak; Mislav Cavka
Journal:  Rheumatol Int       Date:  2011-12-31       Impact factor: 2.631

4.  Remarkable polymorphism of HLA-B27: an ongoing saga.

Authors:  Muhammad Asim Khan
Journal:  Curr Rheumatol Rep       Date:  2010-10       Impact factor: 4.592

5.  Pathophysiology of spondyloarthritis.

Authors:  Monika Ronneberger; Georg Schett
Journal:  Curr Rheumatol Rep       Date:  2011-10       Impact factor: 4.592

6.  [Early axial spondyloarthritis. Diagnostic approach and screening].

Authors:  D Poddubnyy; M Rudwaleit; J Sieper
Journal:  Z Rheumatol       Date:  2012-01       Impact factor: 1.372

7.  Seronegative spondyloarthropathies in Greece: a population-based study of prevalence, clinical pattern, and management. The ESORDIG study.

Authors:  P Trontzas; A Andrianakos; S Miyakis; K Pantelidou; E Vafiadou; V Garantziotou; C Voudouris
Journal:  Clin Rheumatol       Date:  2005-04-29       Impact factor: 2.980

Review 8.  The Japanese experience with biologic therapies for rheumatoid arthritis.

Authors:  Tsutomu Takeuchi; Hideto Kameda
Journal:  Nat Rev Rheumatol       Date:  2010-09-28       Impact factor: 20.543

Review 9.  Campylobacter reactive arthritis: a systematic review.

Authors:  Janet E Pope; Adriana Krizova; Amit X Garg; Heather Thiessen-Philbrook; Janine M Ouimet
Journal:  Semin Arthritis Rheum       Date:  2007-03-13       Impact factor: 5.532

10.  High frequencies of HLA-B27 in Chinese patients with suspected of ankylosing spondylitis.

Authors:  Xiang Liu; Yi-Rong Li; Li-Hua Hu; Zhi-Ming Zhou; Feng-Hua Chen; Yong Ning; Qun-Feng Yao
Journal:  Rheumatol Int       Date:  2009-09-23       Impact factor: 2.631

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.